Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "ANNALS OF ONCOLOGY"

Add to list
- Conference Paper
- C3
miRNA expression profiles in BRCA1-associated breast cancers reveal upregulation of specific miRNAs in tumors lacking a clear second hit in a large proportion of the tumour

Mattias Van Heetvelde (UGent) , Mieke R Van Bockstal, Jo Van Dorpe (UGent) , Kim De Leeneer (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)

(2019) ANNALS OF ONCOLOGY. 30(suppl. 3).
Add to list
- Conference Paper
- C3
Splenic metabolic activity as biomarker in cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo (UGent) , Lien Lippens (UGent) , Kathia De Man (UGent) , Mieke Van Bockstal, Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Pieter De Visschere (UGent) , Olivier De Wever (UGent) , et al.

(2019) ANNALS OF ONCOLOGY. 30(5).
Add to list
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial

RS Herbst, P Baas, JL Perez-Gracia, E Felip, D-W Kim, J-Y Han, JR Molina, J-H Kim, C Dubos Arvis, M-J Ahn, et al.

(2019) ANNALS OF ONCOLOGY. 30(2). p.281-289
Add to list
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, S Gillessen, N James, S Maclennan, J Palou, et al.

(2019) ANNALS OF ONCOLOGY. 30(11). p.1697-1727
Add to list
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, PR Debruyne, S Henry, S Zanetta, A Rutten, LF Licitra, et al.

(2019) ANNALS OF ONCOLOGY. 30(suppl. 5). p.v449-v450
Add to list
Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

E Calvo, A Spira, H Prenen, Y Ohe, Sylvie Rottey (UGent) , A Gazzah, M Millward, V Moreno, A Italiano, T Alanko, et al.

(2019) ANNALS OF ONCOLOGY. 30(suppl. 5). p.v715-v716
Add to list
Bone sarcomas : ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, S Bonvalot, I Boukovinas, JVMG Bovee, B Brennan, et al.

(2018) ANNALS OF ONCOLOGY. 29(suppl. 4). p.79-95
Add to list
- Conference Paper
- C3
Rectal cancer survivorship : the struggle of the low anterior resection syndrome (LARS)

Eva Pape (UGent) , Piet Pattyn (UGent) , Ann Van Hecke (UGent) , N Somers, Dirk Van de Putte (UGent) , Wim Ceelen (UGent) , E van Daele, Wouter Willaert (UGent) and Yves Van Nieuwenhove (UGent)

(2018) ANNALS OF ONCOLOGY. 29(suppl. 8).
Add to list
- Conference Paper
- C3
Nurse led follow-up for CML patients on oral cancer treatment

Sofie De Wilde (UGent) , Johan De Munter (UGent) , Marijke Quaghebeur (UGent) , Dominiek Mazure (UGent) , Annelies De Pauw (UGent) and Barbara Casteels (UGent)

(2018) ANNALS OF ONCOLOGY. 29(suppl. 8).
Add to list
Different menopausal hormone regimens and risk of breast cancer

Nele Brusselaers (UGent) , RM Tamimi, P Konings, B Rosner, HO Adami and J Lagergren

(2018) ANNALS OF ONCOLOGY. 29(8). p.1771-1776

Academic Bibliography

miRNA expression profiles in BRCA1-associated breast cancers reveal upregulation of specific miRNAs in tumors lacking a clear second hit in a large proportion of the tumour

Splenic metabolic activity as biomarker in cervical cancer

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

Bone sarcomas : ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Rectal cancer survivorship : the struggle of the low anterior resection syndrome (LARS)

Nurse led follow-up for CML patients on oral cancer treatment

Different menopausal hormone regimens and risk of breast cancer

Contents

Support

Contact